O'Shaughnessy Asset Management’s BioLife Solutions BLFS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-929	Closed	-$39K	–	1395
2021 Q3	$39K	Hold	929	–	–	﹤0.01%	1749
2021 Q2	$41K	Hold	929	–	–	﹤0.01%	1650
2021 Q1	$33K	Hold	929	–	–	﹤0.01%	1522
2020 Q4	$37K	Buy	+929	New	+$31.7K	﹤0.01%	1308

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

O'Shaughnessy Asset Management's BLFS Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of BioLife Solutions (BLFS) in Q4 2021, closing a stake of 929 shares — an estimated $39K sold.

O'Shaughnessy Asset Management first reported a position in BLFS in Q4 2020 and held it in 4 quarters. The position peaked at $41K in Q2 2021. 169 funds tracked by Wall St. Rank hold BLFS as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining BioLife Solutions position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 929 BioLife Solutions shares in Q4 2021, an estimated $39K.
O'Shaughnessy Asset Management first reported a position in BioLife Solutions in Q4 2020 and held it in 4 quarters.
O'Shaughnessy Asset Management's BioLife Solutions position peaked at $41K in Q2 2021.
169 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.